ARC Medical Private Investor Briefing - Virtual
Dear Investors:
Please join us for an invitation only virtual private investor meeting on Zoom, featuring ARC Medical, on Tuesday, April 21, 2026.
This session is hosted by Opus8 in collaboration with the New York Private Equity Forums (NYPEF).
ARC is one of the most exciting life sciences companies we have seen! ARC significantly improves surgical patient recovery by preventing internal adhesions, the most common complication in knee, shoulder, gynecological and abdominal surgeries.
Key Investment Considerations
Massive Markets: 11 million patients yearly and a TAM $11 billion
Excellent Efficacy and Clinical Data: for company’s lead products for knee and shoulder surgeries
Strong IP Provide Exclusivity: multiple patents granted that provide exclusivity for the company’s products through 2039 and beyond.
Great Fundrasing traction: ARC has already raised $39 million ($21M in equity and $18M in non-dilutive revenue and grants), and will close the current round in a matter of weeks.
Unicorn-level Exit Potential: representing a 20X return based on comparable companies in the wound healing arena.
World Class Team: has designed, developed multi $billion products for companies including J&J, Stryker, Smith+Nephew, Amgen and Moderna
Event Details:
Date: April 21
Time: 11:30 AM EDT
Location: Online via Zoom
Please note that this meeting is for DIRECT and ACTIVE Accredited investors only. All RSVPs must be pre-registered on this Eventbrite site with the investor criteria filled out. All RSVPs are subject to review and approval. We will provide a confirmation email and a calendar invitation after you register.
Request investor materials by contacting Avery North at [email protected]
Thanks much and all the best,
Tien Wong
CEO
Opus8, Inc.